These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 2249621)

  • 1. Glucose transporter in insulin sensitive tissues of lean and obese mice. Effect of the thermogenic agent BRL 26830A.
    Le Marchand-Brustel Y; Olichon-Berthe C; Grémeaux T; Tanti JF; Rochet N; Van Obberghen E
    Endocrinology; 1990 Dec; 127(6):2687-95. PubMed ID: 2249621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a thermogenic agent, BRL 26830A, on insulin receptors in obese mice.
    Rochet N; Tanti JF; Grémeaux T; Van Obberghen E; Le Marchand-Brustel Y
    Am J Physiol; 1988 Aug; 255(2 Pt 1):E101-9. PubMed ID: 2841863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased glucose transporter (GLUT 4) content in insulin-sensitive tissues of obese aurothioglucose- and monosodium glutamate-treated mice.
    Machado UF; Shimizu Y; Saito M
    Horm Metab Res; 1993 Sep; 25(9):462-5. PubMed ID: 8225198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes.
    Cawthorne MA; Carroll MJ; Levy AL; Lister CA; Sennitt MV; Smith SA; Young P
    Int J Obes; 1984; 8 Suppl 1():93-102. PubMed ID: 6152558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents.
    Arch JR; Ainsworth AT; Ellis RD; Piercy V; Thody VE; Thurlby PL; Wilson C; Wilson S; Young P
    Int J Obes; 1984; 8 Suppl 1():1-11. PubMed ID: 6152555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue.
    Santalucía T; Camps M; Castelló A; Muñoz P; Nuel A; Testar X; Palacin M; Zorzano A
    Endocrinology; 1992 Feb; 130(2):837-46. PubMed ID: 1370797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cold acclimation on the expression of glucose transporter Glut 4.
    Olichon-Berthe C; Van Obberghen E; Le Marchand-Brustel Y
    Mol Cell Endocrinol; 1992 Nov; 89(1-2):11-8. PubMed ID: 1301380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
    Young PW; Cawthorne MA; Coyle PJ; Holder JC; Holman GD; Kozka IJ; Kirkham DM; Lister CA; Smith SA
    Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of BRL 26830A for 9 weeks improves insulin sensitivity but does not prevent weight gain in gold-thioglucose obese mice.
    Bryson JM; Wensley VR; Phuyal JL; Caterson ID; Cooney GJ
    Horm Metab Res; 1999 May; 31(5):317-22. PubMed ID: 10422727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazoxide enhances adipose tissue protein kinase B activation and glucose transporter-4 expression in obese Zucker rats.
    Alemzadeh R; Zhang J; Tushaus K; Koontz J
    Med Sci Monit; 2004 Mar; 10(3):BR53-60. PubMed ID: 14976464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced content and preserved translocation of glucose transporter (GLUT 4) in white adipose tissue of obese mice.
    Machado UF; Shimizu I; Saito M
    Physiol Behav; 1994 Apr; 55(4):621-5. PubMed ID: 8190786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle.
    Camps M; Castelló A; Muñoz P; Monfar M; Testar X; Palacín M; Zorzano A
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):765-72. PubMed ID: 1554359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of adipose tissue glucose transporters in genetic obesity (fatty rat). Selective increase in the adipose cell/muscle glucose transporter (GLUT 4) expression.
    Hainault I; Guerre-Millo M; Guichard C; Lavau M
    J Clin Invest; 1991 Mar; 87(3):1127-31. PubMed ID: 1999492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-obesity and anti-diabetic actions of a beta 3-adrenoceptor agonist, BRL 26830A, in yellow KK mice.
    Yoshida T; Hiraoka N; Yoshioka K; Hasegawa G; Kondo M
    Endocrinol Jpn; 1991 Aug; 38(4):397-403. PubMed ID: 1687027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate supply for thermogenesis induced by the beta-adrenoceptor agonist BRL 26830A.
    Wilson S; Thurlby PL; Arch JR
    Can J Physiol Pharmacol; 1987 Feb; 65(2):113-9. PubMed ID: 2882828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adipose cell size on the measurement of GLUT 4 in white adipose tissue of obese mice.
    Fabres-Machado U; Saito M
    Braz J Med Biol Res; 1995 Mar; 28(3):369-76. PubMed ID: 8520534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of three weeks administration of the beta-adrenoceptor agonist BRL 26830A.
    Connacher AA; Bennet WM; Jung RT; Rennie MJ
    Int J Obes Relat Metab Disord; 1992 Sep; 16(9):685-94. PubMed ID: 1356939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
    Garvey WT; Maianu L; Huecksteadt TP; Birnbaum MJ; Molina JM; Ciaraldi TP
    J Clin Invest; 1991 Mar; 87(3):1072-81. PubMed ID: 1999488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients.
    Yki-Järvinen H; Vuorinen-Markkola H; Koranyi L; Bourey R; Tordjman K; Mueckler M; Permutt AM; Koivisto VA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):795-9. PubMed ID: 1517369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.